SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:prod.swepub.kib.ki.se:151288986"
 

Search: onr:"swepub:oai:prod.swepub.kib.ki.se:151288986" > Primary analysis of...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Primary analysis of ProTEct-MS, a randomised, placebocontrolled, phase 2 study of temelimab for the prevention of neurodegenerationin rituximab-treated patients with relapsing multiple sclerosis

Piehl, F (author)
Cree, BA (author)
Granberg, T (author)
show more...
Granziera, C (author)
Al Nimer, F (author)
Andersson, M (author)
Karolinska Institutet
Barakovic, M (author)
Fink, K (author)
Ouelette, R (author)
Sandberg, E (author)
Kuhle, J (author)
Wojcik, J (author)
Berthuy, N (author)
Medina, J (author)
Kremer, D (author)
Kury, P (author)
Leppert, D (author)
show less...
 (creator_code:org_t)
2022
2022
English.
In: MULTIPLE SCLEROSIS JOURNAL. - 1352-4585. ; 28:3_SUPPL, s. 95-96
  • Conference paper (other academic/artistic)
Subject headings
Close  

Publication and Content Type

vet (subject category)
kon (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view